Arylpyridazinones as selective cyclooxygenase-2 inhibitors

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.12, 1999-12, pp. : 1733-1738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective inhibitors of cyclooxygenase-2

By Talley J.J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 55-62

Informa Healthcare

Access to resources Recommend Favorite

Potent and selective cyclooxygenase-2 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 79-80

Informa Healthcare

Access to resources Recommend Favorite

Potent and selective cyclooxygenase-2 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 3, 1997-03 ,pp. : 275-276

Informa Healthcare

Access to resources Recommend Favorite

Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention

By Menter David G

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1749-1764

Informa Healthcare

Access to resources Recommend Favorite

Balancing Gastroprotection and Cardioprotection with Selective Cyclo-Oxygenase-2 Inhibitors: Clinical Implications

By Meagher E.A.

Drug Safety, Vol. 26, Iss. 13, 2003-01 ,pp. : 913-924

Adis International

Access to resources Recommend Favorite